The search for more accurate methods to diagnose clinically significant prostate cancer continues to evolve. While biparametric MRI (bpMRI) is a common clinical tool, its reliance on PI-RADS version 2.1 often results in relatively low specificity. Consequently, researchers are investigating novel techniques like size-selective diffusion MRI to address these diagnostic limitations. In this prospective study, the team compared the performance of bpMRI against selective size imaging using filters via diffusion times (SSIFT-MRI).

Advancing Diagnosis with Size-Selective Diffusion MRI

Specifically, the study evaluated 118 men with suspected clinically significant prostate cancer (csPCa). Researchers utilized pulsed and oscillating gradient spin-echo sequences on a 3T MRI scanner to capture high-resolution data. Additionally, three radiologists assessed the images using both bpMRI and SSIFT-MRI protocols. To ensure accuracy, pathology reports from biopsies or prostatectomies confirmed the cancer status of each patient.

Furthermore, the team compared the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity for both methods. The results indicated that size-selective diffusion MRI provides a more nuanced view of the prostate's cellular landscape. However, the most significant advantage appeared when combining PI-RADS with SSIFT-MRI data. This combination outperformed standard bpMRI, suggesting a potential shift in how clinicians might approach prostate imaging in the future.

Clinical Implications of SSIFT-MRI

Ultimately, improving specificity is vital for reducing unnecessary biopsies and avoiding overdiagnosis. By filtering signals based on diffusion times, size-selective diffusion MRI isolates cellular information more effectively than traditional sequences. Therefore, this technique helps radiologists differentiate between aggressive lesions and benign tissue with higher precision. As a result, the integration of SSIFT-MRI into routine practice could significantly refine the screening process for men's health.

Frequently Asked Questions

What is size-selective diffusion MRI?

Size-selective diffusion MRI, or SSIFT-MRI, is an advanced imaging technique that uses specific diffusion times to filter signals. This allows for better visualization of cellular structures and helps identify clinically significant prostate cancer more accurately than traditional methods.

How does SSIFT-MRI compare to biparametric MRI?

While biparametric MRI is effective, it often has lower specificity. SSIFT-MRI aims to improve diagnostic performance by providing clearer differentiation between cancerous and non-cancerous tissues, potentially reducing false positives and improving accuracy.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Cheng H et al. Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer With Biparametric Versus Size-Selective Diffusion MRI. J Magn Reson Imaging. 2026 Mar 15. doi: 10.1002/jmri.70297. PMID: 41833541.

Turkbey B, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. European Urology. 2019;76(3):340-351.